Track Clover Health Investments, Corp. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Clover Health Investments, Corp. CLOV · Stock Open Clover Health Investments, Corp. in new tab

4.96 USD
P/E
496.00
EPS
0.01
P/B
6.77
ROE
3.40
Beta
2.48
Target Price
5.60 USD
Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

🧾 Earnings Recap – Q1 2026

Shares jumped 16.4% post-earnings, reflecting investor approval of Clover Health's 51% year-over-year membership growth and return to GAAP net income profitability, underscoring confidence in the company’s tech-driven care model and scalable Medicare Advantage platform.

  • Membership increased 51% year-over-year, driven primarily by growth in core New Jersey PPO markets.
  • GAAP net income returned to positive $27 million this quarter, signaling improved financial discipline and operating leverage.
  • Over one-third of members received Clover Assistant-powered care, supporting the company’s targeted clinical engagement strategy.
  • Management moderated in-year growth to prioritize clinical integration, aiming for sustainable cohort economics versus short-term expansion.
  • Positioned well for 2027 with CMS maintaining stable risk adjustment and favorable regulatory changes supporting encounter-based documentation.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2027
P/E496.00
EPS0.01
Book Value0.73
Price to Book6.77
Debt/Equity1.07
% Insiders4.383%
Growth
Revenue Growth0.53%
Estimates
Forward P/E27.56
Forward EPS0.18
Target Mean Price5.60

DCF valuation

Model fair value for Clover Health Investments, Corp. (CLOV)
Result
Sign in to run the valuation for CLOV.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
5 analysts · consensus Buy · mean target 5.60 USD (low 5.00, high 6.00) · as of 15 Nov 2026
Low 5.00
Mean 5.60
High 6.00
Price 4.96
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Clover Health Investments, Corp. Logo Clover Health Investments, Corp. Analysis (CLOV)

United States Health Care Official Website Stock

Is Clover Health Investments, Corp. a good investment? Clover Health Investments, Corp. (CLOV) is currently trading at 4.96 USD. Market analysts have a consensus price target of 5.60 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 496.00. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Clover Health Investments, Corp. is expected to release its next earnings report on Feb. 25, 2027. The market consensus estimate for Forward EPS is 0.18.

Investor FAQ

Does Clover Health Investments, Corp. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Clover Health Investments, Corp.?

Clover Health Investments, Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2027. The company currently has a trailing EPS of 0.01.

Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Exchange Ticker
NMS (United States) CLOV
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2021
0.10 USD
Aug. 23, 2021 0.1000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion